Please login to the form below

Not currently logged in
Email:
Password:

binge eating disorder

This page shows the latest binge eating disorder news and features for those working in and with pharma, biotech and healthcare.

Shire pitching at adult ADHD product launch in 2017

Shire pitching at adult ADHD product launch in 2017

The FDA has agreed a regulatory route for Shire's attention deficit hyperactivity disorder (ADHD) product for adults, potentially opening up a lucrative new market for the company's franchis e. ... Breaking into the adult ADHD - as well as a sideways

Latest news

  • Monica Seles to front Shire’s binge eating disorder campaign Monica Seles to front Shire’s binge eating disorder campaign

    Seles recently admitted to experiencing binge eating disorder when she was a professional tennis player in the 1990s. ... There is a misconception that adults with binge eating disorder fit a certain profile,” said Seles.

  • Shire gets FDA nod for first binge-eating treatment Shire gets FDA nod for first binge-eating treatment

    Vyvanse already available as ADHD treatment. Shire's big-selling Vyvanse brand has become the first drug approved in the US to help people with binge-eating disorder. ... Binge eating disorder is not just about eating a lot; it is that, plus being out of

  • Shire to file Vyvanse for binge-eating in Q3 Shire to file Vyvanse for binge-eating in Q3

    Shire is planning a marketing application in binge-eating in the third quarter, which, if approved, would be the first FDA-backed drug for the condition, potentially adding tens of millions ... Shire wants to achieve with binge-eating disorder what it

  • Shire's ADHD drug fails in depression trial Shire's ADHD drug fails in depression trial

    Company drops Vyvanse for use in major depressive disorder. Shire's hopes to expand the uses of its big-selling behavioural medicine Vyvanse were dashed after the drug disappointed in a ... of adults with binge eating disorder.

  • Shire weathers generic Adderall XR challenge Shire weathers generic Adderall XR challenge

    attention deficit-hyperactivity disorder (ADHD) drug Adderall XR (amphetamine and dextroamphetamine). ... Russell highlighted developments, such as potential new indications for Vyvanse, including major depressive disorder, binge eating disorder and

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics